ASPEN PHARMACARE HOLDINGS LIMITED - Release date of Aspen’s Interim Results for the six months ended 31 December 2020 and Results Presentation
Release date of Aspen’s Interim Results for the six months ended 31 December 2020 and Results Presentation
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
(“Aspen” or “the Company”)
RELEASE DATE OF ASPEN’S INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2020 AND
RESULTS PRESENTATION
Shareholders are referred to Aspen’s announcement of 1 March 2021 wherein it was confirmed that its
results for the six months ended 31 December 2020 on SENS would be released after the market close on
Thursday, 11 March 2021. These results are now to be released after the market closes on the preceding
day, Wednesday, 10 March 2021. All other arrangements around the virtual presentation to the investment
community, the invitation to all interested stakeholders to join the webcast and the availability of the
playback of the webcast after the presentation remain unchanged.
Durban
04 March 2021
Sponsor:
Investec Bank Limited
Date: 04-03-2021 10:52:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
